Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned
ATH434-201 Trial on Track to Complete Enrollment in Q3 2023 Top-Line Data Expected by the…
ATH434-201 Trial on Track to Complete Enrollment in Q3 2023 Top-Line Data Expected by the…
Company Secures Schedule 1 Controlled Substance Manufacturing License from Drug Enforcement Agency, Expands on 25…
Company Secures Schedule 1 Controlled Substance Manufacturing License from Drug Enforcement Agency, Expands on 25…
CAMBRIDGE, Mass., July 26, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage…
CAMBRIDGE, Mass., July 26, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage…
MALVERN, Pa., July 26, 2023 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA),…
MALVERN, Pa., July 26, 2023 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA),…
WATERTOWN, Mass., July 26, 2023 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company…
WATERTOWN, Mass., July 26, 2023 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company…
Perceptive Advisors leads round to execute study in patients with wet age-related macular degeneration (wet…
Perceptive Advisors leads round to execute study in patients with wet age-related macular degeneration (wet…
LONDON, Ontario, July 26, 2023 (GLOBE NEWSWIRE) — Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA:…
LONDON, Ontario, July 26, 2023 (GLOBE NEWSWIRE) — Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA:…
Cell therapy CDMO spins out of Inceptor Bio to help innovators develop and manufacture life-saving…
Cell therapy CDMO spins out of Inceptor Bio to help innovators develop and manufacture life-saving…
PETACH TIKVA, Israel, July 26, 2023 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the…
PETACH TIKVA, Israel, July 26, 2023 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the…
AC Immune SA Appoints New Chief Medical Officer Nuno Mendonça, MD appointed new Chief Medical…
AC Immune SA Appoints New Chief Medical Officer Nuno Mendonça, MD appointed new Chief Medical…
Record Q4 Net Revenue of $184 Million, Representing 20% Growth Year over Year, $627 Million…